Navigation Links
Artificial disc brings increased mobility and rapid recovery to patients suffering chronic neck pain in the Midwest
Date:11/15/2012

KANSAS CITY, Mo., Nov. 15, 2012 /PRNewswire-USNewswire/ -- For many years cervical fusion was the only surgical option for patients suffering from chronic neck pain or single cervical disc degeneration.  The recent creation and approval of artificial discs have offered patients a new treatment option which allows greater mobility and range of motion and dramatically improved recovery times.  However, these initial artificial discs utilized hardware such as screws and pins.

On Nov. 13, 2012, H. Dennis Mollman, M.D., Ph.D. of Saint Luke's Neuroscience Institute of Kansas City, performed the first Bryan Disc surgery in Missouri, Kansas and Iowa, offering patients in the Midwest a new option for dealing with chronic neck pain. The Bryan Disc is an artificial cervical disc replacement which requires no hardware and can simply slide in and replace the patient's damaged natural disc.

"In the past cervical fusion was the standard treatment option," said Dr. Mollman, "Fusing the bones together limited range of motion and generally required a three month recovery as we waited for the bones to grow together.  The Bryan Disc allows patients to retain or regain range of motion and most are back to their normal activities within two weeks, a vastly improved recovery time."

As opposed to a lengthy cervical fusion surgery of four to six hours, the Bryan Disc surgery takes approximately 45 minutes. Patients generally leave the hospital the next day.  According to Dr. Mollman, these factors, coupled with the fact the Bryan Disc more closely resembles the patient's own natural disc, make it an appealing treatment option for patients considering cervical fusion or disc replacement.

More information about Dr. Mollman and the Bryan Disc can be found at https://www.saintlukeshealthsystem.org/docoffice/saint-luke-s-neurosurgery-clinic and http://wwwp.medtronic.com/Newsroom/NewsReleaseDetails.do?itemId=1244730407543&lang=en_US respectively.

About the Saint Luke's Neuroscience Institute

Saint Luke's Neuroscience Institute, a member of Saint Luke's Health System, is a global leader in utilizing both drug and mechanical interventions to block and reverse the permanent and debilitating effects of acute strokes. Its legacy of innovation began in 1993 when doctors performed one of the world's first intra-arterial stroke reversal procedures. Since then, Saint Luke's specialists have continued to pioneer new stroke therapies and reverse stroke's debilitating effects for thousands of patients, and is one of the world's most experienced and prolific leaders in the use of tPA, a clot-busting medication for treatment of acute ischemic stroke.   SLNI, headquartered in Kansas City,  brings together a team of the country's most accomplished neurologists to provide a comprehensive treatment center for the most complex neurological issues.


'/>"/>
SOURCE Saint Luke's Health System
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. 1st SynCardia Total Artificial Heart Patient Discharged from Ankara University in Turkey
2. Study Results of Artificial Disc Recipients Show Significant Improvement Compared to Pre-Surgery Condition
3. Global Artificial Implants Industry
4. Global Artificial Tears Industry
5. SynCardia Total Artificial Heart Patient Featured in U.S. News & World Reports "Best Hospitals" Issue
6. Global Artificial Organs Industry
7. Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in Artificial Pancreas
8. 50% of U.S. News & World Reports "Best Hospitals" for Cardiology & Heart Surgery Making the SynCardia Total Artificial Heart Part of Their Toolbox
9. 1st SynCardia Total Artificial Heart Implant Performed in New England
10. 3 Pediatric Centers that Offer SynCardia Total Artificial Heart Named in Top 10 for "Best Childrens Hospitals"
11. Feasibility of Artificial Pancreas System Demonstrated in Real-World Setting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... Mass. , March 22, 2017  Applied ... mechanistic modeling to drug research and development, today ... Day 2017.  QSP Day 2017 is a day ... the quantitative systems pharmacology (QSP) community. The focus ... modeling is de-risking and accelerating drug research and ...
(Date:3/22/2017)... March 22, 2017 Hologic, Inc. (Nasdaq: ... the acquisition of Cynosure, Inc., a leader in medical ... cash. "We are pleased to complete our ... Michael Davin and the entire Cynosure team ... growing medical aesthetics market," said Steve MacMillan , ...
(Date:3/22/2017)... YORK , March 22, 2017 ... (EP) market is growing rapidly due to the significant ... report published by Allied Market Research, the global electrophysiology ... expected to reach $8.271 billion by 2022, with a ... and is used to diagnose abnormal heartbeats or arrhythmia. ...
Breaking Medicine Technology:
(Date:3/22/2017)... ... March 22, 2017 , ... An intensive search of the medical literature has ... Norins, MD, PhD. He says investigating this possibility, is important because Miami-Dade ... in new infections with HIV. , His findings appear on Analizir.com. ...
(Date:3/22/2017)... MA San Antonio, TX (PRWEB) , ... March ... ... and ISO certified medical imaging core lab with extensive therapeutic experience and operational ... a multi-year phase II immuno-oncology clinical trial for the treatment of non-small cell ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Jim ... regional families and business owners, is joining the Teen Recovery Solutions organization in ... area. , A growing number of Oklahoma teens and adolescents face problems from ...
(Date:3/22/2017)... ... 22, 2017 , ... College basketball surges to its peak during the March ... that is, recruiting people to be foster parents. Through a televised spot, Coach Self ... foster care due to abuse, neglect and other family challenges. People who respond to ...
(Date:3/22/2017)... ... ... Nearly a decade after it was first recommended that men over the ... to stir controversy. The US Preventative Services Task Force (USPSTF) issued a recommendation against ... news from a study published in JAMA Oncology suggests that more men ...
Breaking Medicine News(10 mins):